Literature DB >> 17522407

Posaconazole prophylaxis in hematologic cancer.

Stefan Weiler, Romuald Bellmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17522407     DOI： 10.1056/NEJMc070471

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole.

Authors:  Purva Khare; Manasi M Chogale; Pratik Kakade; Vandana B Patravale
Journal:  Drug Deliv Transl Res       Date:  2022-05-10       Impact factor: 5.671

Review 2.  Posaconazole : a review of its use in the prophylaxis of invasive fungal infections.

Authors:  James E Frampton; Lesley J Scott
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  A multicenter phase 2 study of empirical low-dose liposomal amphotericin B in patients with refractory febrile neutropenia.

Authors:  Kotaro Miyao; Masashi Sawa; Mio Kurata; Ritsuro Suzuki; Reona Sakemura; Toshiyasu Sakai; Tomonori Kato; Satomi Sahashi; Natsuko Tsushita; Yukiyasu Ozawa; Motohiro Tsuzuki; Akio Kohno; Tatsuya Adachi; Keisuke Watanabe; Kaneyuki Ohbayashi; Yuichiro Inagaki; Yoshiko Atsuta; Nobuhiko Emi
Journal:  Int J Hematol       Date:  2016-09-30       Impact factor: 2.319
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.